Mass.-based biotech company Editas Medicine Inc. appointed Jessica Hopfield as a board member.
Hopfield is the chairperson of the board for Joslin Diabetes Center and serves as the lead independent director on the board at Insulet Corp.
Editas Medicine names board member
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Mass.-based biotech company Editas Medicine Inc. appointed Jessica Hopfield as a board member.
Hopfield is the chairperson of the board for Joslin Diabetes Center and serves as the lead independent director on the board at Insulet Corp.